Qinghua Meng

机构：Tianjin University of Sport, Chinese Academy of Sciences, United Therapeutics (United States), National Center for Nanoscience and Technology, Beijing Children’s Hospital, Beijing YouAn Hospital, Shanxi Provincial Children's Hospital, Hangzhou Dianzi University · ORCID：0000-0002-5522-9852

发表论文 187 篇 · 总被引 1772 次 · h-index 24

代表论文

• Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition) (2024 · BioScience Trends · 被引 20)
• Protection against cancer therapy-induced cardiovascular injury by planed-derived polyphenols and nanomaterials (2023 · Environmental Research · 被引 19)
• A viologen-based Cd( ii ) coordination polymer as a multifunctional platform for photochromism, chemochromism and a broad range of fluorescence pH sensing (2023 · Dalton Transactions · 被引 18)
• Advancements in Spiropyran probes: Mechanisms, applications in detection and imaging (2025 · Dyes and Pigments · 被引 17)
• P-element-Induced Wimpy-Testis-Like Protein 1 Regulates the Activation of Pancreatic Stellate Cells Through the PI3K/AKT/mTOR Signaling Pathway (2022 · Digestive Diseases and Sciences · 被引 12)
• Rapid Preparation of Collagen/Red Blood Cell Membrane Tubes for Stenosis-Free Vascular Regeneration (2025 · ACS Nano · 被引 11)